Wearable Smartwatches for Atrial Fibrillation Detection and Burden Estimation After Ablation: Comparison With Continuous Monitoring
Open Access
- 10 November 2025
- journal article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (9)
Abstract
Background: Wearable ECG-enabled smartwatches have been validated for atrial fibrillation (AF) screening, but their accuracy for monitoring AF recurrence and quantifying AF burden after catheter ablation is uncertain. Objectives: To evaluate the simulated performance of three commercial smartwatch algorithms for AF recurrence detection and AF burden estimation compared with implantable cardiac monitors (ICMs). Methods: Using continuous ICM data from 346 patients in the CIRCA-DOSE trial, we simulated three smartwatch algorithms, assuming daytime wear (8:00 AM–10:00 PM). We also simulated commonly-used non-invasive intermittent rhythm monitoring strategies. Primary endpoints were sensitivity for arrhythmia recurrence and correlation with ICM-derived AF burden. Analyses were stratified by daily wear time and patient activity. Results: AF recurrence occurred in 47.1% of patients. Simulated detection sensitivities were 82.2% (Apple Watch AF Burden), 70.6% (Apple Watch IRN), and 64.4% (Fitbit IHRD), compared with 15.8%–64.6% for simulated intermittent AECG monitors. Wearables outperformed commonly-used Holter/patch monitoring strategies. AF burden correlation with ICM exceeded r = 0.97 for all algorithms. Among missed recurrences, median AF burden was 90% with 24-hour use), whereas patient activity modestly reduced detection. Conclusions: Smartwatch-based AF detection algorithms demonstrate strong correlation with ICM-derived AF burden and clinically good sensitivity for recurrence detection, outperforming conventional non-invasive strategies. These findings support the integration of wearables as a scalable alternative for post-ablation rhythm monitoring.Keywords
Funding Information
- André Chagnon Research Chair in Electrophysiology
- Congenital Heart Disease
This publication has 40 references indexed in Scilit:
- Atrial fibrillation: epidemiology, screening and digital healthThe Lancet Regional Health - Europe, 2024
- Ablation to Reduce Atrial Fibrillation Burden and Improve OutcomesJACC, 2023
- Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020JAMA Network Open, 2023
- Clinical Validation of 5 Direct-to-Consumer Wearable Smart Devices to Detect Atrial FibrillationJACC: Clinical Electrophysiology, 2023
- Atrial fibrillation detection using ambulatory smartwatch photoplethysmography and validation with simultaneous holter recordingAmerican Heart Journal, 2022
- Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation AblationJAMA Cardiology, 2021
- Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatchHeart Rhythm, 2021
- Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devicesHeart Rhythm, 2021
- The WATCH AF Trial: SmartWATCHes for Detection of Atrial FibrillationJACC: Clinical Electrophysiology, 2019
- Passive Detection of Atrial Fibrillation Using a Commercially Available SmartwatchJAMA Cardiology, 2018